lactitol has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castells, L; Coll, I; Fernández-Rodríguez, C; Mas, A; Pardo, A; Planas, R; Rodés, J; Rodrigo, L; Rodríguez-Martínez, D; Sunyer, L; Vargas, V | 1 |
| Arroyo, V; Caballería, J; Heredia, D; Ravelli, G; Rodés, J | 1 |
2 trial(s) available for lactitol and Acute Disease
| Article | Year |
|---|---|
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.
Topics: Acute Disease; Ammonia; Anti-Infective Agents; Double-Blind Method; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged; Recurrence; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Treatment Outcome | 2003 |
Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols | 1987 |